CD8A and neoplasm: On the other hand, AMD3100, alone or combined with VIC-008, was able to suppress PD-1 expression on CD8+ T cells and to reduce tumor-infiltrating immunosuppressive Tregs, possibly by mediating their conversion into helper-like cells.